Osaic Holdings’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$137 Sell
66
-2,000
-97% -$3.94K ﹤0.01% 7812
2026
Q1
$3.62K Buy
2,066
+2,000
+3,030% +$3.64K ﹤0.01% 6830
2025
Q4
$155 Buy
+66
New +$127 ﹤0.01% 7606
2023
Q4
Sell
-15
Closed -$128 7417
2023
Q3
$128 Hold
15
﹤0.01% 7202
2023
Q2
$376 Buy
15
+7
+88% +$175 ﹤0.01% 7105
2023
Q1
$426 Buy
8
+7
+700% +$246 ﹤0.01% 7160
2022
Q4
$0 Hold
1
﹤0.01% 7366
2022
Q3
$0 Hold
1
﹤0.01% 7440
2022
Q2
$0 Sell
1
-4
-80% -$1.93K ﹤0.01% 7528
2022
Q1
$4K Buy
+5
New +$4.04K ﹤0.01% 6621
2021
Q4
Hold
0
7516
2021
Q3
Hold
0
7272
2021
Q2
Hold
0
7094
2021
Q1
Hold
0
6681
2020
Q4
Hold
0
6527
2020
Q3
Hold
0
6354
2020
Q2
Hold
0
6270
2020
Q1
Hold
0
6148

Other funds holding PALI

Osaic Holdings's PALI Position: Q2 2026 in Review

Osaic Holdings reduced its Palisade Bio (PALI) stake by 97% in Q2 2026, selling an estimated $3.94K and leaving 66 shares worth $137. The position accounts for ﹤0.01% of the portfolio, ranked #7812.

Osaic Holdings first reported a position in PALI in Q1 2022 and has held it in 10 quarters since. The position peaked at $4K in Q1 2022. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Osaic Holdings held 66 shares of Palisade Bio worth $137 as of Q2 2026.
  • Osaic Holdings sold 2,000 Palisade Bio shares in Q2 2026, an estimated $3.94K.
  • Palisade Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7812 holding.
  • Osaic Holdings first reported a position in Palisade Bio in Q1 2022 and has held it in 10 quarters since.
  • Osaic Holdings's Palisade Bio position peaked at $4K in Q1 2022.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.